Biodistribution and scintigraphic evaluation of 99mTc-Mannan complex

Area of Science:

• Nuclear Medicine
• Radiopharmaceutical Development
• Immunology

Background:

• Mannan, a Toll-like receptor (TLR) agonist, is explored for its potential to modulate biological effects of ionizing radiation.
• Previous in vitro and in vivo studies suggest mannan influences radiation response.
• Understanding mannan's in vivo behavior is crucial for its therapeutic applications.

Purpose of the Study:

• To radiolabel mannan with Technetium-99m (99mTc) for biodistribution studies.
• To evaluate the pharmacologic biodistribution of 99mTc-mannan complex in mice via oral, intraperitoneal (i.p.), and intravenous (i.v.) routes.
• To assess the in vivo stability and clearance mechanisms of the 99mTc-mannan complex.

Main Methods:

• Direct radiolabeling of mannan with 99mTc using Tin(II) Chloride Dihydrate.
• Qualitative and quantitative analysis using ITLC-SG and ascending paper chromatography.
• In vivo biodistribution studies in BALB/c mice and New Zealand white rabbits using scintigraphic imaging and radiometry.

Main Results:

• High radio-complexation efficiency (>98%) and stability of 99mTc-mannan complex confirmed.
• Oral administration resulted in minimal absorption, with radioactivity localized in the stomach and small intestine.
• Parenteral (i.p. and i.v.) administration led to significant accumulation in liver, kidney, spleen, lungs, and other organs, indicating hepatobiliary and renal clearance.

Conclusions:

• The biodistribution of 99mTc-mannan complex is highly dependent on the route of administration.
• Parenteral administration facilitates systemic distribution, while oral administration leads to fecal excretion.
• This study provides foundational data for understanding mannan's in vivo pharmacokinetics and its potential role in radiation modulation.